Qube Research & Technologies Ltd - ATARA BIOTHERAPEUTICS INC ownership

ATARA BIOTHERAPEUTICS INC's ticker is ATRA and the CUSIP is 046513107. A total of 124 filers reported holding ATARA BIOTHERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is 0.01 and the average weighting 0.2%.

Quarter-by-quarter ownership
Qube Research & Technologies Ltd ownership history of ATARA BIOTHERAPEUTICS INC
ValueSharesWeighting
Q2 2023$56,202
-69.4%
34,908
-37.7%
0.00%
-100.0%
Q4 2022$183,670
-16.5%
55,997
+136.6%
0.00%
-50.0%
Q1 2022$220,000
-27.9%
23,670
+20.7%
0.00%
-33.3%
Q2 2021$305,000
-74.0%
19,606
-76.0%
0.00%
-84.2%
Q1 2021$1,175,000
+32.3%
81,795
+80.9%
0.02%
+46.2%
Q4 2020$888,00045,2240.01%
Other shareholders
ATARA BIOTHERAPEUTICS INC shareholders Q1 2023
NameSharesValueWeighting ↓
BRIDGER MANAGEMENT, LLC 2,932,865$48,304,0003.48%
Camber Capital Management LP 2,950,000$48,587,0002.47%
Trellus Management Company, LLC 87,873$1,447,0002.42%
Redmile Group, LLC 4,648,570$76,562,0001.83%
Baupost Group 8,308,900$136,848,0001.51%
MAVERICK CAPITAL LTD 4,958,431$81,665,0001.19%
Artal Group S.A. 1,750,000$28,823,0001.11%
PACIFIC HEIGHTS ASSET MANAGEMENT LLC 175,000$2,882,0000.36%
12 West Capital Management LP 158,700$2,614,0000.16%
WASATCH ADVISORS LP 1,101,103$18,135,0000.15%
View complete list of ATARA BIOTHERAPEUTICS INC shareholders